Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors
Mai Sugahara, Tetsuhiro Tanaka, Masaomi Nangaku
Topics & Concepts
MedicineErythropoietinAnemiaKidney diseaseErythropoiesisClinical trialHypoxia-inducible factorsIntensive care medicineHypoxia (environmental)DialysisPharmacologyInternal medicineGeneOxygenOrganic chemistryChemistryBiochemistryErythropoietin and Anemia TreatmentBlood transfusion and managementCancer, Hypoxia, and Metabolism